Cytosorbents (CTSO) Other Non-Current Assets (2010 - 2026)
Cytosorbents' (CTSO) quarterly Other Non-Current Assets came in at $1.5 million in Q1 2026, little changed YoY from $1.5 million in Q1 2025, and up 2771.7% on a QoQ basis from $53000.0 in Q4 2025.
Cytosorbents (CTSO) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Other Non-Current Assets data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Other Non-Current Assets changed 0.03% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (changed 0.03% YoY) and the FY2025 annual result came in at $53000.0, down 96.43% from the prior year.
- Other Non-Current Assets rose to $1.5 million in Q1 2026, from $53000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $6.5 million in Q3 2024 to a low of $53000.0 in Q4 2025.
- A 5-year average of $2.7 million and a median of $1.7 million in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 284.24% — and 2025, when it sank 96.43%.
- Tracing CTSO's Other Non-Current Assets over 5 years: stood at $4.4 million in 2022, then slumped by 66.56% to $1.5 million in 2023, then gained by 0.0% to $1.5 million in 2024, then slumped by 96.43% to $53000.0 in 2025, then soared by 2771.7% to $1.5 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.5 million (Q1 2026), $53000.0 (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | 53,000.00 |
| Sep 30, 2025 | 1.52 Mn |
| Jun 30, 2025 | 3.79 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 6.48 Mn |
| Jun 30, 2024 | 3.77 Mn |
| Mar 31, 2024 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 4.45 Mn |
| Dec 31, 2022 | 4.44 Mn |
| Sep 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | 4.67 Mn |
| Mar 31, 2022 | 4.68 Mn |
| Dec 31, 2021 | 4.96 Mn |
| Sep 30, 2021 | 4.87 Mn |